Article Text

Download PDFPDF

Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis
  1. T Hiratsuka1,
  2. H Mukae4,
  3. H Iiboshi1,
  4. J Ashitani1,
  5. K Nabeshima2,
  6. T Minematsu3,
  7. N Chino6,
  8. T Ihi5,
  9. S Kohno4,
  10. M Nakazato1
  1. 1Third Department of Internal Medicine, Miyazaki Medical College, Miyazaki, Japan
  2. 2Second Department of Pathology, Miyazaki Medical College, Miyazaki
  3. 3Department of Microbiology, Miyazaki Medical College, Miyazaki
  4. 4Second Department of Internal Medicine of Nagasaki University School of Medicine, Nagasaki, Japan
  5. 5National Sanatorium Miyazakihigashi Hospital, Osaka, Japan
  6. 6Peptide Institute Inc, Osaka, Japan
  1. Correspondence to:
    Dr H Mukae, The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki, Japan 852-8501;


Background: Human β-defensin (HBD)-1 and -2 are antimicrobial peptides present in the respiratory tract. Recent reports have indicated reduced activity of β-defensins in cystic fibrosis, suggesting that β-defensins may play an important role in the pathological process of chronic respiratory tract infection. Diffuse panbronchiolitis (DPB) is a progressive disease characterised by frequent episodes of superimposed infection, typically caused by Pseudomonas aeruginosa. The aim of this study was to elucidate the role of these antimicrobial peptides in this disease.

Methods: The concentrations of HBD-1 and HBD-2 in plasma and bronchoalveolar lavage (BAL) fluid from 33 patients with DPB and 30 normal adults were measured by radioimmunoassay. Localisation of HBD-2 was investigated immunohistochemically in an open lung biopsy specimen obtained from a patient with DPB.

Results: High concentrations of HBD-1 and HBD-2 were noted in BAL fluid from DPB patients. Increased plasma concentrations of HBD-2, but not HBD-1, were found in patients with DPB compared with control subjects. In patients with DPB the HBD-2 concentration in BAL fluid correlated significantly with the numbers of cells recovered from the BAL fluid (total cells, neutrophils, and lymphocytes) and with the BAL fluid concentration of IL-1β. Synthetic HBD-2, but not HBD-1, had dose dependent bactericidal activity against P aeruginosa. Treatment of 14 patients with macrolides significantly reduced BAL fluid concentrations of HBD-2 but not HBD-1 or plasma concentrations of HBD-1 and HBD-2. Immunohistochemistry of lung tissue showed localisation of HBD-2 in the epithelia of the distal bronchioles.

Conclusions: These results indicate that β-defensins, particularly HBD-2, participate in antimicrobial defence in the respiratory tract in DPB, and that the BAL fluid concentration of HBD-2 may be a useful marker of airway inflammation in patients with DPB.

  • human β-defensin-1,2
  • diffuse panbronchiolitis
  • bronchoalveolar lavage fluid
View Full Text

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Airwaves
      Wisia Wedzicha